Navigation Links
National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
Date:8/19/2007

re focused on the improvement of the quality of life for patients and their families. National Stem Cell Holding, Inc. is headquartered in Mountainside, NJ.

Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)," "feel(s)," "believe(s)," "will," "may," "anticipate(s)" and similar expressions are intended to identify forward-looking statements, which include, but are not limited to statements regarding: the ability of the Company to perform clinical trials, the ability of the biomaterials to promote tissue repair and the variety of wound care applications. All of such forward-looking statements are not guarantees of future performance. They are based on management's current expectations and are subject to risks and uncertainties that are difficult to predict and generally beyond the control of the Company, and that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, but are not limited to: the risk that the patent applications will not be granted, the risk that the analysis of future data will not warrant continuation of development; the risk that the FDA, the institutional review boards for the clinical sites or the investigators may not agree with the Company's assessment of the results and may not permit future trials; the risk that concerns may arise from additional analysis or data; and the risk that the Company may encounter other unexpected hurdles. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. National Stem Cell Holding, Inc. does not undertake any obli
'/>"/>

SOURCE National Stem Cell Holding, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire/--SwissrayInternational,Inc.ale...systems,announcedtodaythatitsoperationshavebeenacq...dsgrowingSwissray,smedicalimagingbrand.Theacquisit...ascontractsandinventory.After25yearsofsuccessandgr...ologicaladvancementswithstableandsteadygrowth. ,...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...ranasalDrugDelivery-USMarketTrends&Analysis h...g-Delivery---US-Market-Trends--Analysis.html ,...xpansionoftherapeuticapplicationsfromthedeliveryof...stemictherapeuticdrugs.Thefutureofthetechnologyhin...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Herbruck Alder to Convene Summit 3A Coming Together to Explain Healthcare Legislation 54254 1Really Think Different 54252 1Really Think Different 54252 2Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 1Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 2Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 3
...rch 6 The American Medical Association (AMA) Foun...09 Seed Grant Research Program. Established in 20...students, physician residents and fellows to condu...jects. This year,s award winners are conducting r... , Cardiovascular/pulmonary diseases , ...
...rmatology Division of Valeant Pharmaceuticals Intr...o Increase Patient Satisfaction and Use , , SAN F...xpanded dermatology division of Valeant Pharmaceut...ay the commercial launch of Acanya(TM) Gel (clinda...dicated for the once-daily treatment of acne vulga...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 2Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 3Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 4Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 5
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--TheBl...nstodetermineexecutiveleadershipfor2010. ,, The...specialtiesinpublicpolicy,law,finance,governmenthe....TheBoardalsocomesfromawiderangeofpersonalbackgrou...,somelivingwithHIVthemselves,andrepresentingmultip...
(Date:11/25/2009)..., BroadPoliticalEndorsements,Business,andPressJo...wswire-USNewswire/--Onceagain,theNationalBipolarFo...tionendorsingtheir"Safe,tilStable"program,whichisn...eforbipolardisorder.Today,theNationalBipolarFounda...pressPriorityMailfromtheLt.GovernorofLouisianaMitc...
(Date:11/25/2009)...earchers have found evidence of a statistically si... among patients whose estrogen receptor (ER)-posit...R-alpha; at serine-118 (ER-alpha S118-P), accordin...er 25 in the Journal of the National Cancer Insti...are resistant to tamoxifen. Preclinical studies ha...
(Date:11/25/2009)...s stress increase blood pressure? This simple que...any years. New Stress-related gene Modulates High...se blood pressure? This simple question has been ... new research has for the first time established a...od pressure response to stress in mice as well as ...
(Date:11/25/2009)...imab, already used to fight rheumatoid arthritis, ..., , WEDNESDAY, Nov. 25 (HealthDay News) ...phoma and rheumatoid arthritis now also shows some...type 1 diabetes. , The drug, rituximab (Rituxan...n insulin, even though the disease had destroyed s...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... Association ( www.UnitedSpinal.org ) encourages w...etropolitan area to call 311 to request a wheelc...ch Program. , , This system links passengers ...connects the passenger to a dispatcher who collect...
...nd Services for Quantros Patient Safety Center Par...antros PSO Manager Technology Platform , , SA...of safety, quality, and compliance solutions for t...edge content in the area of medication errors prev...
...dings, Inc.,(OTC Bulletin Board: ZTMH) issued the ...Photo: http://www.newscom.com/cgi-bin/prnh/200812...reholders:, , "It was the best of times; it ...n many ways, the phrase is applicable to the story...
...researchers have found that a new combination of m...mproved or stabilized multiple myeloma for 76 perc...eatment. , Interim results of an ongoing clinica...of the American Society of Hematology in San Franc...
...PRNewswire-FirstCall/ - Bradmer Pharmaceuticals In...evelopment and commercialization of cancer therapi...sident and Chief Executive Officer of Bradmer will...he panel titled, Antibody Strategies For Fighting ...
...women at tasks that require rotating an object men...psychologists at Pitzer College and UCLA have disc...in infancy and can be found in boys as young as 5 ...e complex objects visually and to mentally rotate ...
Other Medicine News:Health News:Accessible Dispatch Program: Accessible Taxi Service for Wheelchair Users in New York City 2Health News:Quantros and ISMP to Partner on PSO Initiatives 2Health News:Quantros and ISMP to Partner on PSO Initiatives 3Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 2Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 3Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 4Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 5Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 6Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 7Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 8Health News:Z Trim Holdings, Inc. Releases Letter to Shareholders 9Health News:Drug combination improves or stabilizes disease for relapsed multiple myeloma patients 2Health News:Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference 2Health News:Psychologists report that a gender gap in spatial skills starts in infancy 2Health News:Psychologists report that a gender gap in spatial skills starts in infancy 3
Operating Otoscope
2.5V PocketScope Otoscope/Throat Illuminator
3.5V MacroViewOtoscope
3.5V MacroViewOtoscope/Throat Illuminator
Medicine Products: